Stibbe advises Agendia

Stibbe advises Agendia

Stibbe advises Agendia

26.07.2018 NL law

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Agendia is a privately held, leading precision oncology company that develops and markets genomic diagnostic products. Proceeds from the financing will accelerate Agendia's commercial expansion in the U.S. and international markets and will enable Agendia to establish new collaborative research programs.


Related experience

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring